{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024960","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.837164+00:00","generated_at":"2026-06-01T02:24:20.194233+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MyMD Pharmaceuticals increases authorized Series G Preferred shares from 8,950 to 12,826,273 for in-kind dividends","bullets":["On June 17, 2024, MyMD filed a Certificate of Amendment to increase authorized Series G Convertible Preferred Stock from 8,950 to 12,826,273 shares.","The amendment enables payment of dividends 'in kind' in the form of additional Preferred Stock shares, per Section 3 of the Certificate of Designations.","The amendment was approved by Required Holders and became effective upon filing with the Delaware Secretary of State.","The Company had previously entered into a Securities Purchase Agreement on May 20, 2024 for sale of Preferred Stock and warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024960","json":"https://secwatch.observer/filing/0001493152-24-024960.json","markdown":"https://secwatch.observer/filing/0001493152-24-024960.md","text":"https://secwatch.observer/filing/0001493152-24-024960.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024960/0001493152-24-024960-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224024960/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:24:20.194233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}